NuChem Sciences Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
300
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
5
- Investments
-
3
NuChem Sciences General Information
Description
Provider of contract research services intended for the pharmaceutical and biotechnology industry. The company's services specialize in the field of medicinal chemistry, drug discovery biology, fragment screening, structure-activity-relationship design and computational drug design, thereby providing customers with relevant data to move their projects forward quickly and efficiently.
Contact Information
Website
www.nuchemsciences.com(Operating Subsidiary)
Corporate Office
- 2350 rue Cohen
- Suite 201
- Saint-Laurent, Quebec H4R 2N6
- Canada
Corporate Office
- 2350 rue Cohen
- Suite 201
- Saint-Laurent, Quebec H4R 2N6
- Canada
NuChem Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
NuChem Sciences Comparisons
Industry
Financing
Details
NuChem Sciences Competitors (19)
One of NuChem Sciences’s 19 competitors is Charnwood Discovery, a Private Equity-Backed company based in Loughborough, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Charnwood Discovery | Private Equity-Backed | Loughborough, United Kingdom | ||||
| Everest Clinical Research | Private Equity-Backed | Markham, Canada | ||||
| Resolian | Private Equity-Backed | Malvern, PA | ||||
| JSS Medical Research | Formerly PE-Backed | Laval, Canada | ||||
| Symeres | Private Equity-Backed | Nijmegen, Netherlands |
NuChem Sciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
NuChem Sciences Patents
NuChem Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230322797-A1 | Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds | Pending | 07-Apr-2022 | ||
| US-20250042897-A1 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use | Pending | 09-Nov-2021 | ||
| US-20230234967-A1 | Fused azole heterocycles as ahr antagonists | Pending | 28-May-2020 | ||
| US-20230331705-A1 | Fused imidazole derivatives as ahr antagonists | Pending | 20-May-2020 | ||
| US-20230002390-A1 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use | Active | 04-May-2020 | A61K45/06 |
NuChem Sciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
NuChem Sciences Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
NuChem Sciences Investments (3)
NuChem Sciences’s most recent deal was a Buyout/LBO with IniXium. The deal was made on 31-Oct-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| IniXium | 31-Oct-2022 | Buyout/LBO | BPO/Outsource Services | ||
| OmegaChem | 17-Aug-2021 | Buyout/LBO | Other Pharmaceuticals and Biotechnology | ||
| Amplia Pharmatek | 31-Oct-2019 | Buyout/LBO | Drug Discovery |
NuChem Sciences Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| IniXium | Laval, Canada | 2014 | |
| Amplia Pharmatek | Montreal, Canada | 2009 | |
| OmegaChem | Levis, Canada | 1988 |
NuChem Sciences FAQs
-
When was NuChem Sciences founded?
NuChem Sciences was founded in 2011.
-
Where is NuChem Sciences headquartered?
NuChem Sciences is headquartered in Saint-Laurent, Canada.
-
What is the size of NuChem Sciences?
NuChem Sciences has 300 total employees.
-
What industry is NuChem Sciences in?
NuChem Sciences’s primary industry is BPO/Outsource Services.
-
Is NuChem Sciences a private or public company?
NuChem Sciences is a Private company.
-
What is NuChem Sciences’s current revenue?
The current revenue for NuChem Sciences is .
-
How much funding has NuChem Sciences raised over time?
NuChem Sciences has raised $30M.
-
Who are NuChem Sciences’s investors?
AmorChem, BDC Capital, Fonds de solidarite FTQ, GeneChem, and Institut De Recherche Clinique De Montreal are 5 of 8 investors who have invested in NuChem Sciences.
-
Who are NuChem Sciences’s competitors?
Charnwood Discovery, Everest Clinical Research, Resolian, JSS Medical Research, and Symeres are some of the 19 competitors of NuChem Sciences.
-
When was NuChem Sciences acquired?
NuChem Sciences was acquired on 31-Jul-2023.
-
Who acquired NuChem Sciences?
NuChem Sciences was acquired by Sygnature Discovery.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
